Nova Oculus and StarFish Engage In Manufacturing Partnership

December 01, 2016 Nova Oculus Partners and StarFish Medical are announcing a collaborative agreement to bring to market a pioneering medical device for the treatment of Age-Related Macular Degeneration. The agreement makes StarFish responsible for the development and manufacturing of the Nova Oculus headset, an integral component of the electrotherapeutic medical device Nova...

Posted on December 02, 2016Read More

Nova Oculus Partners Appoints Jeffrey Gibbs as Consultant for Regulatory Affairs

Nova Oculus Partners, LLC (NOP) announces the appointment of Jeffrey N. Gibbs as its new Consultant for Regulatory Affairs. As a director with the Washington, D.C.-based firm Hyman, Phelps & McNamara, Mr. Gibbs has extensive experience in “FDA law,” working with the Food and Drug Administration in the areas of product approvals and enforcement actions. In recent years,...

Posted on October 25, 2016Read More

Nova Oculus Partners Revolutionize AMD Treatment

If you are looking to invest in a company that has the forward vision in the field of ophthalmology, Nova Oculus Partners is the key. Their innovative team has revolutionized the treatment of age-related macular degeneration (AMD). Age-related macular degeneration affects millions of Americans. This eye condition clouds the central vision making it very difficult to do...

Posted on October 20, 2016Read More

Nova Oculus Partners Develop Revolutionary Technology

Nova Oculus Partners Develop Revolutionary Technology

Try to imagine how it feels to look at your phone and not see anything but a dark spot in the center of it? This is what it is like to live with age-related macular degeneration. It affects all aspects of life from driving a car to the store to reading the newspaper or dialing a phone number. These everyday tasks that most people perform without issues are very difficult for...

Posted on October 04, 2016Read More

Nova Oculus Partners Discover a Method to Treat Age-Related Macular Degeneration

A deterioration of the central vision of a patient’s eye is the cause for Age-Related Macular Degeneration (AMD). Most affected are over the age of 60 years old. The good news is that Nova Oculus Partners have created a specific technology that will treat AMD. For those who suffer from age-related macular degeneration, their eyes form a “black cloud” in the central...

Posted on September 09, 2016Read More